SU1192614A3 - Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof - Google Patents

Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof Download PDF

Info

Publication number
SU1192614A3
SU1192614A3 SU813301195A SU3301195A SU1192614A3 SU 1192614 A3 SU1192614 A3 SU 1192614A3 SU 813301195 A SU813301195 A SU 813301195A SU 3301195 A SU3301195 A SU 3301195A SU 1192614 A3 SU1192614 A3 SU 1192614A3
Authority
SU
USSR - Soviet Union
Prior art keywords
group
alkyl
hydrogen
pyrido
alkoxy
Prior art date
Application number
SU813301195A
Other languages
Russian (ru)
Inventor
Хермец Иштван
Кекеши Йожеф
Хорват Агнеш
Месарош Золтан
Сас Дьердь
Брайнинг Тибор
Вашвари Лелле
Original Assignee
Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие) filed Critical Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие)
Application granted granted Critical
Publication of SU1192614A3 publication Critical patent/SU1192614A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the general formula <IMAGE> (wherein R, R<1> and R<2>, which may be the same or different, each represents a hydrogen or halogen atom or a nitro, carboxy, cyano, C1-4 alkoxy, C1-4 alkyl, amino, or hydroxy group or an alkoxycarbonyl group in which the alkoxy contains 1 to 4 carbon atoms; or R and R<1> together represent a methylenedioxy group, and R<2> represents a hydrogen atom; R<3> represents a hydrogen atom or a C1-4 alkyl group; R<4> represents a hydrogen atom or a C1-4 alkyl group, a naphthyl or pyridyl group or a phenyl group substituted by 1 to 3 substituents, which may be the same or different, selected from halogen, C1-4 alkyl, C1-4 alkoxy, phenoxy, hydroxy, nitro, amino, cyano, carboxy, alkoxycarbonyl in which the alkoxy moiety contains 1 to 4 carbon atoms, alkanoyl in which the alkyl moiety contains 1 to 4 carbon atoms, methylenedioxy, trifluoromethyl, phenyl and mono- or di-alkylamino in which the alkyl moiety contains 1 to 4 carbon atoms; and each dotted line represents an optional further bond and the salts, optical and geometrical isomers and tautomers thereof are intermediates in the preparation of Rutaecarpine and the analogues thereof. The compounds of formula I may be prepared by reaction of a pyrido[2,1-b]quinazolin-11-one with a diazonium salt or with hydrazine or a derivative thereof.

Description

1one

Изобретение относитс  к способу получени  новых производных 6-гид- разино-пиридо( 2,1--в)-хиназолин-11она общей формулыThis invention relates to a process for the preparation of new derivatives of 6-hydrazino-pyrido (2,1-b) quinazoline-11one of the general formula

нитрогруппу, карбоксил, нитрил, С Ц - алкоксил, C -С4 алкоксикарбанил , С4-С(ралкил, аминогруппу или гидроксигруппу,nitro, carboxyl, nitrile, C C - alkoxy, C-C4 alkoxycarbanyl, C4-C (ralkyl, amino group or hydroxy group,

9261492614

разбавл ют лед ной уксусной кислотой и затем пр;капывают раствор 2,0 г (о,01 моль) 11-оксо 6,7,8,9-тетрагидро- 1 Н-пиридо-(2 ,1-в)хиназолииа е в 10 мл 50%-ной уксусной кислоты. Реакционную смесь перемешивают при (5) О С в течение 3 ч и затем оставл ют на ночь в холодильнике. Выпавшие кристаллы отфильтровывают и промывают водой. Полученные diluted with glacial acetic acid and then a solution of 2.0 g (o, 01 mol) 11-oxo 6,7,8,9-tetrahydro-1 H-pyrido (2, 1-b) quinazolium-e 10 ml of 50% acetic acid. The reaction mixture was stirred at (5) 0 C for 3 hours and then left in the refrigerator overnight. The precipitated crystals are filtered and washed with water. Received

10 6-фенилгидразоно-11-оксо-6,7,8,9-тетрагидро-11Н-пиридо- (2,1-в)-хиназолины в случае необходимости молгно перекристаллизовать из н-пропа- иола.10 6-phenylhydrazono-11-oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1-b) -quinazolines, if necessary, instantaneously recrystallize from n-propa-iol.

1515

Полученные соединени  указаны в табл. 1.The compounds obtained are listed in Table. one.

и R вместе метилендиоксиили R цand R together methylenedioxy R c

группу;group;

R - водород;г- R is hydrogen; g-

R4 - водород илиС(,С1 -алкил, известных услови х одно-трехкратно, одинаково или по-разному замещенный галогеном, С4-С4.-алкилом, С -С -алкоксилом , фенилоксилом, гидроксилом, нитрогруппой, аминогруппой, циано- группой, карбоксилом, C/j-С -алкокси- карбонилом, С 5-С4-алканоилом, метилендиоксигруппой , трифторметилом, фенилом, С -С -дналкиламиногруппой, фенил, нафтил или пиридил,R4 is hydrogen or C (, C 1 -alkyl, known conditions one or three times, equally or differently substituted by halogen, C 4 -C 4 -alkyl, C-C-alkoxy, phenyloxy, hydroxyl, nitro, amino, cyano, carboxyl, C / j-C-alkoxy-carbonyl, C 5 -C4-alkanoyl, methylenedioxy, trifluoromethyl, phenyl, C-C -dalkylamino, phenyl, naphthyl or pyridyl,

пунктирна  лини  при определенных услови х имеюща с  друга  С -С св зь ,the dotted line, under certain conditions, is a C-C bond from a friend,

или их солей, которые могут быть применены .в качестве исходных веществ при получении алкалоидов.or their salts, which can be used as starting materials in the preparation of alkaloids.

Цель изобретени  - синтез новых соединений,  вл ющихс  исходными дл  получени  алкалоидов.The purpose of the invention is the synthesis of new compounds that are the starting material for the preparation of alkaloids.

Реакцию провод т при ( j - О С в смеси воды с органическим растворителем или в органическом растворителе , смешивающимс  с водой.The reaction is carried out at (j-O C in a mixture of water with an organic solvent or in an organic solvent miscible with water.

В качестве инертного органического растворител  можно примен ть ал- канкарбоновые кислоты .Alkane carboxylic acids can be used as the inert organic solvent.

Примеры 1-22,Examples 1-22

К смеси из 0,01 моль производного анилина и 5 мл 1: разбавленной 28%ной водной сол ной кислоты медленно , при -5 С и при перемешивании и охлаждении, прикапьшают 0,69 г ,(0,01 моль) нитрата натри  в 5 мл воды. Реакционную смесь перемешивают при (-5) в течение 0,5 ч, после чего устанавливают рН реакционной смеси путем добавки ацетата натри  равным 4. Реакционную смесьTo a mixture of 0.01 mol of aniline derivative and 5 ml of 1: diluted 28% aqueous hydrochloric acid slowly, at -5 ° C and with stirring and cooling, 0.69 g, (0.01 mol) of sodium nitrate in 5 ml of water. The reaction mixture was stirred at (-5) for 0.5 h, after which the pH of the reaction mixture was adjusted by adding sodium acetate to 4. The reaction mixture

Примеры 23 и 24. Процесс ведут аналогично примерам 1-22, однако вместо 11-оксо-6,7,8,9-тетрагидро-11Н-пиридо- (2,1-в)-хиназолина используют 11-оксо-1,2,3,4,6,7,8-окта-гидро-1 1 Н-пиридо-( 2, 1-в)-хиназолин .Examples 23 and 24. The process is carried out similarly to examples 1-22, however, instead of 11-oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1-b) -quinazoline use 11-oxo-1,2 , 3,4,6,7,8-octa-hydro-1 1 H-pyrido (2, 1-b) -quinazoline.

Полученные соединени  представлены в табл. 1,The compounds obtained are presented in Table. one,

., Примеры 25-28. Процесс ведут аналогично примерам 1-22, однако в качестве исходного вещества в примере 25 используют 2,3,4-триметокси-11-оксо-6 ,7,8,9-тетрагидро- -11Н-пиридо-{2,1-в)-хиназолина, в примере 26 11-оксо-6,7,8,9-тетра- гидро-11 Н-пиридо-( 2,1 -в )-хиназолин-2-карбоновую кислоту, в примере 27 метил- 1-оксо-6,7,8,9-тетрагидро-11Н-пиридо- (2,1-в)-хиназо- ЛИН-2-карбоксилат, а в примере 28 1I-оксо-6,7,8,9-тетрагидро-11Н-пи- ридо-{2,1-в)-хиназолин, ., Examples 25-28. The process is carried out analogously to examples 1-22, however, 2,3,4-trimethoxy-11-oxo-6, 7,8,9-tetrahydro-11H-pyrido {2,1-b ) -quinazoline, in example 26, 11-oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1 -b) -quinazoline-2-carboxylic acid, in example 27 methyl-1- oxo-6,7,8,9-tetrahydro-11H-pyrido- (2,1-b) -quinazo-LIN-2-carboxylate; in example 28, 1I-oxo-6,7,8,9-tetrahydro- 11H-pyrido- {2,1-b) quinazoline,

Полученные производные 6-фенилгидразоно- 1 1-оксо-6,7,8,9-тетрагид- ро-11Н-пиридо-{2,1-в)-хиназолина указаны в табл. 1.The resulting 6-phenylhydrazono-1 1-oxo-6,7,8,9-tetrahydro-11H-pyrido {2,1-b) -quinazoline derivatives are listed in the table below. one.

Продукты могут перекристаллизо- выватьс  из н-пропанола.Products may be recrystallized from n-propanol.

Пример 29. 0,93 г (0,01 моль) анилина раствор ют в5 мл 1:1 разбавленной 38%-ной водной сол ной кислоты при -5 С, после чего при посто нном перемещивании и охлаждении прикапывают 0,69 г (0,01 ммоль) нитрата натри  в 5 мл воды. Реакционную смесь перемешивают в течение 0,5 ч при -5 - О С, после чего рН устанавливают равным 4 путем добавки ацетата натри  и смесь разбавл ют 10 мл уксусной кис-.Example 29. 0.93 g (0.01 mol) of aniline is dissolved in 5 ml of 1: 1 diluted 38% aqueous hydrochloric acid at -5 ° C, then 0.69 g (0) is added dropwise with constant displacement and cooling. , 01 mmol) of sodium nitrate in 5 ml of water. The reaction mixture is stirred for 0.5 hours at -5 ° C, after which the pH is adjusted to 4 by addition of sodium acetate and the mixture is diluted with 10 ml of acetic acid.

33

лоты. К смеси затем медленно и при интенсивном перемешивании прикапывают раствор 2,28 г (0,01 моль) 6-ч1)ормил-1 1 -оксо-б ,7,8, Э-тетр агид- ро 1Н-пиридо--(2,)-хиназолина в 30 МП уксусной кислоты Реакционную смесь перемепшвают при в течение i ч и- затем оставл ют на ночь в холодильнике. Выделившиес  кристаллы отфильтровывают и промывают водой. Получают 3,1 г (91 % б-фенил- гидразоно- 6,7,8,9-тетрагидро-11 -ок со-11Н-пиридо-(2,)-тсиназолингидр ,хлорида с т.пл. 255®С.lots. A solution of 2.28 g (0.01 mol) of 6-h1) Ormyl-1 1 -oxo-b, 7.8, E-tetr agidro 1H-pyrido- (2 ,) - quinazoline in 30 MP of acetic acid. The reaction mixture is stirred for i h and then left overnight in a refrigerator. The precipitated crystals are filtered and washed with water. 3.1 g (91% of b-phenylhydrazono-6,7,8,9-tetrahydro-11-co-11H-pyrido- (2,) - tsinazolinghydr, chloride, mp 255 ° C are obtained.

Вычислено, %: С 63,60; Н 5,04; N 16,48; С1 0,16.Calculated,%: C 63.60; H 5.04; N 16.48; C1 0.16.

c,gH N4001c, gH N4001

Найдено, %: С 63,44; Н 4,98; N 16,59; С1 10,11.Found,%: C 63.44; H 4.98; N 16.59; C1 10.11.

Примеры 30-40. Процесс ведут аналогично примерам 23 и 24, использу  в качестве исходных веществ производные Н-оксо-1 ,2,3,4- 6,7,8-октагидро-11Н-пиридо-(2,1-в)хнназолина .Examples 30-40. The process is carried out analogously to examples 23 and 24, using as starting materials derivatives of H-oxo-1, 2,3,4- 6,7,8-octahydro-11H-pyrido- (2,1-in) hnnazoline.

Получают производные 6-фенилгидразоио-11 -юксо-1,2,3,4,6,7,8-октагидро-I1Н-пиридо- (2,1-в)-хиназолинаDerived 6-phenylhydrazio-11-yuco-1,2,3,4,6,7,8-octahydro-I1H-pyrido- (2,1-b) -quinazoline

Вьзделившиес  после диазосв зывани  кристаллы суспендируютс  в 5%- ном растворе гидроокиси натри , после чего водный раствор встр хивают с хлороформом. Высушенный над плав- леньш сульфатом натри  хлороформный раствор выпаривают и остаток кристаллизуют.The crystals separated out after diazo-bonding are suspended in 5% sodium hydroxide solution, after which the aqueous solution is shaken with chloroform. The chloroform solution dried over sodium sulfate is evaporated and the residue is crystallized.

Пример 41.О,46 г (0,005 моль) анилина раствор ют в 3 мл I:1 разбавленной 38%-ной сол ной кислоты при -5с, после чегоExample 41.O., 46 g (0.005 mol) of aniline is dissolved in 3 ml of I: 1 diluted 38% hydrochloric acid at -5 s, after which

26142614

при посто нном перемешивании и охлаждении прикапьшают 0,35 г (0,005 моль) нитрита натри  в 3 мл воды. Реакционную смесь переметива- с ют при (-5)- в течение 0,5 ч, после чего рН устанавливают равным 4 путем добавки ацетата натри . К смеси медленно прикапывают раствор 6-формил-11-ОКСО-1,2,3,4,6,7,8-окта10 гидро-15 Н-пиридо-(2,1-в)-хиназолина в 15 мл 75%-ной уксусной кислоты. Реакционную смесь перемешивают при температуре ниже в течение 3ч, затем оставл ют на ночь в холоднль- IJ нике и разбавл ют 30 мл воды. Ъыпазшие кристап ш отфильтровывают и про- Ш1вают водой. Получают 1,3 г (73%) 6-фенилгидразиио- 11 -оксо-1,2,3,4,6, 8-ок та гидро- I Н-пиридо- (2., 1 -в) -хина- 20 золингидрохлорида с. т.пл. 242-244 С.under constant stirring and cooling, 0.35 g (0.005 mol) of sodium nitrite is added in 3 ml of water. The reaction mixture was taken up at (-5) for 0.5 h, after which the pH was adjusted to 4 by addition of sodium acetate. A solution of 6-formyl-11-OXO-1,2,3,4,6,7,8-octa-10 hydro-15 H-pyrido- (2,1-b) -quinazoline in 15 ml of 75% - is slowly added dropwise to the mixture. acetic acid. The reaction mixture is stirred at a temperature below for 3 hours, then left overnight in cold water and diluted with 30 ml of water. The crustaceans that are left are filtered and rinsed with water. 1.3 g (73%) of 6-phenylhydrazio-11-oxo-1,2,3,4,6, 8-okta hydro-I H-pyrido- (2., 1-b) -hina-20 are obtained. zoling hydrochloride with. m.p. 242-244 C.

& 1числемо, %: С 63,59; Н N 15,61; С 9,88. &Amp; N,%: C 63.59; H N 15.61; From 9.88.

Найдено, %: С 63,21; Н 6,28; 25 N 5,75; С 9,65.Found,%: C 63.21; H 6.28; 25 N 5.75; From 9.65.

Соединени  общей-формулы (I) но- гут быть использованы дл  получени  новых апкапондов - аналогов рутекап- рина общей формулы по чвперу .Compounds of general formula (I) are used to produce new up-pockets — analogues of rucapprin of general formula for a chopper.

Мочегонное действие новых алкалоидов и известного рутекарпина пр ведено в табл. 2.The diuretic effect of new alkaloids and the well-known rutecarpine is shown in Table. 2

Из приведенных данных следует, что полученные из пр,едлагаемых проI From the data it follows that obtained from the pr, the subject proI

межуточных соединений алкалоиды оказывают значительно более сильное мочегонное действие по сравнению с рутекарпином .interstitial compounds alkaloids have a significantly stronger diuretic effect compared with rutecarpine.

Таблица 2table 2

СамкаFemale

Новый алкалоид .New alkaloid.

СамецMale

Метилцел- Methylcel-

То же 5 лозольвSame 5 lozolv

РутекарпинRutecarpine

13,56 13.56

. 10,05 14,17 10,42. 10.05 14.17 10.42

3,8 3.8

5,05 4,35 6,08 4.75 7,15 4,80 7,105.05 4.35 6.08 4.75 7.15 4.80 7.10

Claims (1)

Способ получения производных 6-гидразино-пиридо-(2,1-в)-хиназолин—11-она общей формулы разному замещенный галогеном, С<—С4— алкилом, С(—С4—алкоксилом, фенилок— силом, гидроксилом, нитрогруппой, аминогруппой, цианогруппой, карбоксилом, С4—С4—алкоксикарбонилом, С(4-алканоилом, метилендиоксигруппой, трифторметилом, фенилом, С4-С^— диалкаиламиногруппой фенил, нафтил или пиридил;The method of obtaining derivatives of 6-hydrazino-pyrido- (2,1-b) -quinazoline-11-one of the general formula is differently substituted with halogen, C <—C4 — alkyl, C (—C4 — alkoxyl, phenyl-silo, hydroxyl, nitro, an amino group, a cyano group, a carboxyl, C4 — C4 — alkoxycarbonyl, C ( —C 4 -alkanoyl, methylenedioxy, trifluoromethyl, phenyl, C 4 —C ^ - dialkylamino group phenyl, naphthyl or pyridyl; пунктирная линия — при определенных условиях имеющаяся другая С-С—связь, или их солей, отличающий— с я тем, что соединения общей формулы где Rf, R2, R3, R4 и пунктирная линия имеют указанные значения;dashed line — under certain conditions, there is another C — C bond, or salts thereof, distinguished by the fact that the compounds of the general formula where R f , R 2 , R 3 , R 4 and the dashed line have the indicated meanings; R6 - водород, формулы формил или группаR 6 is hydrogen, formyl formulas or a group N где Rj, R2 и R3 - одинаковые или разные и означают водород, галоген, нитрогруппу, карбоксил, нитрил, С|-С4-алкоксил, С{-С4-алкоксикар— бонил, С^-С^-алкил, аминогруппу или гидроксигруппу, или R, и R2 - вместе метиленди— оксйгруппа;N where Rj, R 2 and R 3 are the same or different and mean hydrogen, halogen, nitro group, carboxyl, nitrile, C | -C4 alkoxy, C {-C4 alkoxycarbonyl, C ^ -C ^ -alkyl, amino or a hydroxy group, or R and R 2 are together methylene dioxy; R3 - водород;R 3 is hydrogen; R^ - водород или Сj-C^-алкил;, R5 - при известных условиях одно-трехкратно, одинаково или по- где - С,-С4-алкил, подвергают взаимодействию с солью диазония общей формулыR ^ - hydrogen or Cj-C ^ -alkyl ;, R 5 - under certain conditions, one to three times, the same or where - C, -C 4 -alkyl, is reacted with a diazonium salt of the general formula Θ ΘΘ Θ R5-N2CI где имеет указанные значения, за исключением атома водорода и С^-С^-алкильной группы, с выделением целевого продукта в свободном виде или в виде соли.R5-N2CI where has the indicated meanings, with the exception of the hydrogen atom and the C ^ -C ^ -alkyl group, with the isolation of the target product in free form or in the form of a salt. 09) SU mi 119261409) SU mi 1192614
SU813301195A 1980-06-24 1981-06-23 Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof SU1192614A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU801559A HU183173B (en) 1980-06-24 1980-06-24 Process for producing 6-hydrazono-pyrido-aracket-2,1-b-bracket closed-quinazolin-11-ones

Publications (1)

Publication Number Publication Date
SU1192614A3 true SU1192614A3 (en) 1985-11-15

Family

ID=10955013

Family Applications (2)

Application Number Title Priority Date Filing Date
SU813301195A SU1192614A3 (en) 1980-06-24 1981-06-23 Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof
SU823436303A SU1191449A1 (en) 1980-06-24 1982-05-18 Derivatives of 6-hydrazonopyrido (2,1-b)quinazolin-11-on as intermediate products in synthesis of indolo(2',3',3,4) pyrido (2,1-b)quinozalin-5-on derivatives possessing diuretic activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU823436303A SU1191449A1 (en) 1980-06-24 1982-05-18 Derivatives of 6-hydrazonopyrido (2,1-b)quinazolin-11-on as intermediate products in synthesis of indolo(2',3',3,4) pyrido (2,1-b)quinozalin-5-on derivatives possessing diuretic activity

Country Status (25)

Country Link
JP (1) JPS5738781A (en)
AT (1) AT379393B (en)
AU (1) AU544360B2 (en)
BE (1) BE889339A (en)
CA (1) CA1167842A (en)
CH (1) CH648312A5 (en)
CS (1) CS296285A2 (en)
DD (1) DD160060A5 (en)
DE (1) DE3124577A1 (en)
DK (1) DK277281A (en)
ES (1) ES503266A0 (en)
FI (1) FI70897C (en)
FR (1) FR2485534A1 (en)
GB (1) GB2080291B (en)
GR (1) GR74608B (en)
HU (1) HU183173B (en)
IL (1) IL63061A (en)
IT (1) IT1144814B (en)
NL (1) NL8102935A (en)
NO (1) NO157142C (en)
PL (2) PL129623B1 (en)
PT (1) PT73248B (en)
SE (1) SE441829B (en)
SU (2) SU1192614A3 (en)
YU (1) YU42722B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194196A (en) * 1979-07-17 1983-07-15 Ici Australia Ltd -(quinoxalin-2-yl(oxy or thio) phen (oxy or ylthio)-alkanoic acid derivatives or precursors
AT377586B (en) * 1981-06-30 1985-04-10 Erba Farmitalia METHOD FOR PRODUCING SUBSTITUTED PYRROLO- (2,1-B) -QUINAZOLINES AND PYRIDO (2,1-B) -QUINAZOLINES
JPS5987269A (en) * 1982-11-12 1984-05-19 Nissan Motor Co Ltd Fuel injection valve
JPS61126367A (en) * 1984-11-24 1986-06-13 Mitsubishi Heavy Ind Ltd Fuel injection device
JPS61129457A (en) * 1984-11-27 1986-06-17 Mitsubishi Heavy Ind Ltd Multi-fuel-valve injector

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Phyllips R. The Japp-Klingemann reaction. - Organic Reactions. - New York, v. 10, p. 143-178. *

Also Published As

Publication number Publication date
YU156481A (en) 1983-09-30
BE889339A (en) 1981-10-16
IT8167869A0 (en) 1981-06-23
PT73248A (en) 1981-07-01
IT1144814B (en) 1986-10-29
JPS5738781A (en) 1982-03-03
GB2080291A (en) 1982-02-03
PL129623B1 (en) 1984-05-31
PL231826A1 (en) 1982-07-05
ES8203370A1 (en) 1982-04-01
DD160060A5 (en) 1983-04-27
FI70897C (en) 1986-10-27
PT73248B (en) 1982-07-22
CS296285A2 (en) 1991-01-15
IL63061A0 (en) 1981-09-13
NO157142C (en) 1988-01-27
PL129635B1 (en) 1984-05-31
NO812143L (en) 1981-12-28
FI811970L (en) 1981-12-25
CH648312A5 (en) 1985-03-15
SE441829B (en) 1985-11-11
CA1167842A (en) 1984-05-22
AU7208181A (en) 1982-01-07
AU544360B2 (en) 1985-05-23
FR2485534A1 (en) 1981-12-31
NO157142B (en) 1987-10-19
FR2485534B1 (en) 1985-01-11
GR74608B (en) 1984-06-29
NL8102935A (en) 1982-01-18
PL235214A1 (en) 1982-10-25
SE8103940L (en) 1981-12-25
GB2080291B (en) 1984-01-18
ATA277081A (en) 1985-05-15
FI70897B (en) 1986-07-18
IL63061A (en) 1985-04-30
YU42722B (en) 1988-12-31
DK277281A (en) 1981-12-25
ES503266A0 (en) 1982-04-01
SU1191449A1 (en) 1985-11-15
HU183173B (en) 1984-04-28
DE3124577A1 (en) 1982-09-23
AT379393B (en) 1985-12-27

Similar Documents

Publication Publication Date Title
SU733516A3 (en) Method of preparing quinazolon derivatives or their salts
SU727142A3 (en) Method of preparing substituted 1-sulfonidebenzimidazoles
WO1993016076A1 (en) 3-(1h^_-tetrazol-5-yl)-4h^_-pyrido[1,2-a^_]pyrimidine-4-ones, pharmaceutical compositions containing the same and the preparation thereof
SU893134A3 (en) Method of preparing imidazo /2,1-b/ thiazoline-or thiazine derivatives in form of mixture or individual isomers or their acid-additive salts
SU1192614A3 (en) Method of producing 6-hydrazino-pyrido-(2,1-b)-quinozalin-11-on derivatives or salts thereof
SU481155A3 (en) Production method - (furyl-methyl) morphinans
JPH0141637B2 (en)
RU2042678C1 (en) Method of synthesis of 6,7-dichloro-1,5-dihydroimidazo-[2,1-b]-quinazoline-2-(3h)-one, intermediates for their synthesis and a method of their synthesis
US3960847A (en) 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
SU1579459A3 (en) Method of obtaining derivatives of 1-methylaminoquinolinecarboxylic acid or their salts connecting pharmaceutically acceptable acids
SU1230468A3 (en) Method of producing derivatives of quinoxaline-1,4-dioxide
EP0138490B1 (en) 4-alkyl methylenedioxy-2-1[H]-quinazolinones
SU419028A3 (en) METHOD OF OBTAINING 2-
JPH0782498A (en) Bisazo compound
PL139429B1 (en) Process for preparing novel,base-substituted 4-phenyl-4,5,6,7-tetrahydro-thieno/2,3-c/pyridines
SU1220570A3 (en) Method of producing derivatives of quinoxalyndioxide
US3953493A (en) Substituted sulfonamide derivatives as anthelmintic agents
US2524802A (en) Hydroxybenzenesulfonamidopyridazines and preparation of same
US4066644A (en) Pyrazolo [1,5-a]pyrido[3,2-e]pyrimidine-7-carboxylic acid heterocyclic derivatives
SU980622A3 (en) Process for producing derivatives of pyrido(1,2,a)pyrimidine, their optical isomermers or their hydrates or salts
Monge‐Vega et al. Synthesis of some new derivatives of 4‐hydrazino‐5H‐pyridazino [4, 5‐b] indole
KR840001286B1 (en) Process for preparation of 2-imidazaline derivatives
SU626694A3 (en) Method of producing benzimidazole derivatives or their salts
US3277096A (en) Process for the preparation of aminohalogeno isoquinolines
SU1705287A1 (en) Derivatives of 2-amino-1,2,3,4-tetrahydroisoquinoline with saluretic effect